- High gross margin of 81.8%
- Strong operating margin of 45.3%
- Healthy interest coverage ratio of 29.1x
Green day on Wednesday for Novo Nordisk A/S
(Updated on Jun 10, 2026)
The Novo Nordisk A/S stock price gained 1.47% on the last trading day (Wednesday, 10th Jun 2026), rising from $42.19 to $42.81. During the last trading day the stock fluctuated 5.69% from a day low at $41.66 to a day high of $44.03. The price has been going up and down for this period, and there has been a -3.91% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 17 million shares were bought and sold for approximately $706.67 million.
The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $41.33 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 23.88% during the next 3 months and, with a 90% probability hold a price between $51.20 and $61.92 at the end of this 3-month period.
NVO Signals & Forecast
There are mixed signals in the stock today. The Novo Nordisk A/S stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $43.72. On a fall, the stock will find some support from the short-term average at $42.52. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, May 13, 2026, and so far it has fallen -9.07%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Novo Nordisk A/S stock
On the downside, the stock finds support just below today's level from accumulated volume at $39.42 and $37.45. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Novo Nordisk A/S finds support just below today's level at $39.42. If this is broken, then the next support from accumulated volume will be at $37.45 and $36.53.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.37 between high and low, or 5.69%. For the last week, the stock has had daily average volatility of 4.08%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (NVO) For The Upcoming Trading Day Of Thursday 11th
For the upcoming trading day on Thursday, 11th we expect Novo Nordisk A/S to open at $42.83, and during the day (based on 14 day Average True Range), to move between $42.09 and $43.53, which gives a possible trading interval of +/-$1.45 (+/-3.44%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 3.44% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $43.90 (2.55%) than the support at $39.42 (7.92%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Novo Nordisk A/S stock A Buy?
Novo Nordisk A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score:
-2.686
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 11, 2026 - $42.83 ( 0.0545%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
NVO Performance
Trading levels for NVO
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 45.20 | 5.59% |
| R2 | 44.30 | 3.48% |
| R1 | 43.74 | 2.17% |
| Price | 42.81 | |
| S1 | 41.93 | -2.06% |
| S2 | 41.37 | -3.37% |
| S3 | 40.46 | -5.48% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 45.76 | 6.89% |
| R2 | 44.39 | 3.69% |
| R1 | 43.90 | 2.55% |
| Price | 42.81 | |
| S1 | 39.42 | -7.92% |
| S2 | 37.45 | -12.52% |
| S3 | 36.53 | -14.67% |
NVO Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 04, 2026 | Mar 30, 2026 | Apr 08, 2026 | $0.92 | 1.92% |
| 2 | Sep 18, 2025 | Sep 18, 2025 | Sep 29, 2025 | $0.0038 | 0.0067% |
| 3 | Aug 18, 2025 | Aug 18, 2025 | Aug 26, 2025 | $0.412 | 0.84% |
| 4 | Feb 05, 2025 | Mar 31, 2025 | Apr 08, 2025 | $0.787 | 1.28% |
| 5 | Aug 16, 2024 | Aug 16, 2024 | Aug 26, 2024 | $0.374 | 0.277% |
FAQ
Click here for our free guide on how to buy Novo Nordisk A/S Stock.
Buy NVO